EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Oral Sodium Bicarbonate vs. Use of Higher Dialysate Bicarbonate in Hemodialysis Patients With Metabolic Acidosis: A Randomized Controlled Trial

Hoda M M Abdulaziz iD, Alaa Sabry, Marwa Saleh, Ghada El-Said

Hemodialysis International · 2025

DOI: 10.1111/hdi.13230 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Hemodialysis International, 2025. Verfasst von Hoda M M Abdulaziz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mansoura Nephrology and Dialysis Unit (MNDU), Department of Internal Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt. Hauptthemen laut MEDLINE: Sodium Bicarbonate, Acidosis, Renal Dialysis, Bicarbonates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The optimal strategy for correcting metabolic acidosis and maintaining acid–base balance in hemodialysis patients remains unclear. This study aimed to evaluate and compare the effects of oral bicarbonate administration vs. increased dialysate bicarbonate concentration on predialysis serum bicarbonate levels in hemodialysis patients with metabolic acidosis.

Methods

This was a single‐center, open‐label, randomized controlled trial. Adult hemodialysis patients with metabolic acidosis (serum bicarbonate < 22 mmol/L) were randomly assigned in a 1:1:1 ratio to one of three treatment groups for 16 weeks: (1) standard dialysate (32 mM bicarbonate plus 3 mM acetate), (2) increased dialysate bicarbonate (34 mM bicarbonate plus 3 mM acetate), or (3) standard dialysate with daily oral sodium bicarbonate supplementation (0.3–0.5 mmol/kg). Of the 75 eligible participants, 66 completed the study. The primary outcome was the difference in predialysis serum bicarbonate levels between the groups at 16 weeks.

Results

Baseline predialysis serum bicarbonate levels averaged approximately 19.5 mmol/L across all three groups. At 16 weeks, there was no statistically significant difference in predialysis serum bicarbonate levels among the groups ( p = 0.701). The mean levels were 20.1 (SD 2.16) mmol/L in the standard dialysate group, 20.5 (SD 2.04) mmol/L in the increased dialysate bicarbonate group, and 20.8 (SD 2.61) mmol/L in the oral supplementation group. Compared to baseline, predialysis bicarbonate levels significantly increased within the increased dialysate bicarbonate group ( p = 0.010) and the oral supplementation group ( p = 0.021), but not in the control (standard dialysate, no oral supplementation) group.

Conclusion

Oral or dialytic bicarbonate supplementation at the doses used in this study demonstrated equivalent effects on predialysis serum bicarbonate concentrations in acidotic hemodialysis patients. However, the amount of supplemental bicarbonate administered via either route was insufficient to achieve the target correction of acidosis (e.g., predialysis serum bicarbonate ≥ 22 mmol/L).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium BicarbonateAcidosisRenal DialysisBicarbonatesDialysis SolutionsHumansMaleFemaleMiddle AgedAdministration, OralAgedAdult

Stichwörter der Autor:innen

dialysate bicarbonate bathhemodialysismetabolic acidosisoral sodium bicarbonate

Substanzen

Sodium BicarbonateBicarbonatesDialysis Solutions

Autor:innen und Institutionen

  • Mansoura Nephrology and Dialysis Unit (MNDU), Department of Internal Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

ORCID-Profile: Hoda M M Abdulaziz

Zitieren

APA

Abdulaziz, H. M. M., Sabry, A., Saleh, M., & El-Said, G. (2025). Oral Sodium Bicarbonate vs. Use of Higher Dialysate Bicarbonate in Hemodialysis Patients With Metabolic Acidosis: A Randomized Controlled Trial. Hemodialysis International. https://doi.org/10.1111/hdi.13230

Vancouver

Abdulaziz HMM, Sabry A, Saleh M, El-Said G. Oral Sodium Bicarbonate vs. Use of Higher Dialysate Bicarbonate in Hemodialysis Patients With Metabolic Acidosis: A Randomized Controlled Trial. Hemodialysis International. 2025. doi:10.1111/hdi.13230

BibTeX
@article{Abdulaziz2025,
  author = {Abdulaziz, Hoda M M and Sabry, Alaa and Saleh, Marwa and El-Said, Ghada},
  title = {Oral Sodium Bicarbonate vs. Use of Higher Dialysate Bicarbonate in Hemodialysis Patients With Metabolic Acidosis: A Randomized Controlled Trial},
  journal = {Hemodialysis International},
  year = {2025},
  doi = {10.1111/hdi.13230}
}
Kostenlos starten →